 | • レポートコード：QYR9ST04750 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がんワクチン薬パイプラインの世界市場について調査・分析し、がんワクチン薬パイプラインの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（治療ワクチン、予防ワクチン）、用途別（外来診療センター、病院）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがんワクチン薬パイプライン市場動向 ・主要企業別マーケットシェア ・がんワクチン薬パイプラインの種類別市場規模2014-2019 （治療ワクチン、予防ワクチン） ・がんワクチン薬パイプラインの用途別市場規模2014-2019 （外来診療センター、病院） ・がんワクチン薬パイプラインの北米市場：主要企業・種類別/用途別市場規模 ・がんワクチン薬パイプラインのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がんワクチン薬パイプラインの中国市場：主要企業・種類別/用途別市場規模 ・がんワクチン薬パイプラインの日本国内市場：主要企業・種類別/用途別市場規模 ・がんワクチン薬パイプラインの東南アジア市場：主要企業・種類別/用途別市場規模 ・がんワクチン薬パイプラインのインド市場：主要企業・種類別/用途別市場規模 ・がんワクチン薬パイプラインの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eisai、F. Hoffmann-La Roche、Arbor Pharmaceuticals、Bristol-Myers Squibb、Merck） ・がんワクチン薬パイプラインの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity.Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers.
In 2018, the global Cancer Vaccines Drug Pipeline market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Vaccines Drug Pipeline status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Vaccines Drug Pipeline development in United States, Europe and China.
The key players covered in this study
Eisai
F. Hoffmann-La Roche
Arbor Pharmaceuticals
Bristol-Myers Squibb
Merck
…
Market segment by Type, the product can be split into
Therapeutic Vaccine
Prophylactic Vaccine
Market segment by Application, split into
Ambulatory Care Centers
Hospital
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Vaccines Drug Pipeline status, future forecast, growth opportunity, key market and key players.
To present the Cancer Vaccines Drug Pipeline development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Vaccines Drug Pipeline are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Vaccines Drug Pipeline Market Size Growth Rate by Type (2014-2025)
1.4.2 Therapeutic Vaccine
1.4.3 Prophylactic Vaccine
1.5 Market by Application
1.5.1 Global Cancer Vaccines Drug Pipeline Market Share by Application (2014-2025)
1.5.2 Ambulatory Care Centers
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Vaccines Drug Pipeline Market Size
2.2 Cancer Vaccines Drug Pipeline Growth Trends by Regions
2.2.1 Cancer Vaccines Drug Pipeline Market Size by Regions (2014-2025)
2.2.2 Cancer Vaccines Drug Pipeline Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Vaccines Drug Pipeline Market Size by Manufacturers
3.1.1 Global Cancer Vaccines Drug Pipeline Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Vaccines Drug Pipeline Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Vaccines Drug Pipeline Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Vaccines Drug Pipeline Key Players Head office and Area Served
3.3 Key Players Cancer Vaccines Drug Pipeline Product/Solution/Service
3.4 Date of Enter into Cancer Vaccines Drug Pipeline Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019)
4.2 Global Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Vaccines Drug Pipeline Market Size (2014-2019)
5.2 Cancer Vaccines Drug Pipeline Key Players in United States
5.3 United States Cancer Vaccines Drug Pipeline Market Size by Type
5.4 United States Cancer Vaccines Drug Pipeline Market Size by Application
6 Europe
6.1 Europe Cancer Vaccines Drug Pipeline Market Size (2014-2019)
6.2 Cancer Vaccines Drug Pipeline Key Players in Europe
6.3 Europe Cancer Vaccines Drug Pipeline Market Size by Type
6.4 Europe Cancer Vaccines Drug Pipeline Market Size by Application
7 China
7.1 China Cancer Vaccines Drug Pipeline Market Size (2014-2019)
7.2 Cancer Vaccines Drug Pipeline Key Players in China
7.3 China Cancer Vaccines Drug Pipeline Market Size by Type
7.4 China Cancer Vaccines Drug Pipeline Market Size by Application
8 Japan
8.1 Japan Cancer Vaccines Drug Pipeline Market Size (2014-2019)
8.2 Cancer Vaccines Drug Pipeline Key Players in Japan
8.3 Japan Cancer Vaccines Drug Pipeline Market Size by Type
8.4 Japan Cancer Vaccines Drug Pipeline Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Vaccines Drug Pipeline Market Size (2014-2019)
9.2 Cancer Vaccines Drug Pipeline Key Players in Southeast Asia
9.3 Southeast Asia Cancer Vaccines Drug Pipeline Market Size by Type
9.4 Southeast Asia Cancer Vaccines Drug Pipeline Market Size by Application
10 India
10.1 India Cancer Vaccines Drug Pipeline Market Size (2014-2019)
10.2 Cancer Vaccines Drug Pipeline Key Players in India
10.3 India Cancer Vaccines Drug Pipeline Market Size by Type
10.4 India Cancer Vaccines Drug Pipeline Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Vaccines Drug Pipeline Market Size (2014-2019)
11.2 Cancer Vaccines Drug Pipeline Key Players in Central & South America
11.3 Central & South America Cancer Vaccines Drug Pipeline Market Size by Type
11.4 Central & South America Cancer Vaccines Drug Pipeline Market Size by Application
12 International Players Profiles
12.1 Eisai
12.1.1 Eisai Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Vaccines Drug Pipeline Introduction
12.1.4 Eisai Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)
12.1.5 Eisai Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Vaccines Drug Pipeline Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 Arbor Pharmaceuticals
12.3.1 Arbor Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Vaccines Drug Pipeline Introduction
12.3.4 Arbor Pharmaceuticals Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)
12.3.5 Arbor Pharmaceuticals Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Vaccines Drug Pipeline Introduction
12.4.4 Bristol-Myers Squibb Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Vaccines Drug Pipeline Introduction
12.5.4 Merck Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)
12.5.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Vaccines Drug Pipeline Key Market Segments
Table Key Players Cancer Vaccines Drug Pipeline Covered
Table Global Cancer Vaccines Drug Pipeline Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Vaccines Drug Pipeline Market Size Market Share by Type 2014-2025
Figure Therapeutic Vaccine Figures
Table Key Players of Therapeutic Vaccine
Figure Prophylactic Vaccine Figures
Table Key Players of Prophylactic Vaccine
Table Global Cancer Vaccines Drug Pipeline Market Size Growth by Application 2014-2025 (Million US$)
Figure Ambulatory Care Centers Case Studies
Figure Hospital Case Studies
Figure Cancer Vaccines Drug Pipeline Report Years Considered
Table Global Cancer Vaccines Drug Pipeline Market Size 2014-2025 (Million US$)
Figure Global Cancer Vaccines Drug Pipeline Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Vaccines Drug Pipeline Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Vaccines Drug Pipeline Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Vaccines Drug Pipeline Market Share by Regions 2014-2019
Figure Global Cancer Vaccines Drug Pipeline Market Share by Regions 2014-2019
Figure Global Cancer Vaccines Drug Pipeline Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Vaccines Drug Pipeline Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Vaccines Drug Pipeline Market Share by Manufacturers (2014-2019)
Figure Global Cancer Vaccines Drug Pipeline Market Share by Manufacturers in 2018
Table Global Cancer Vaccines Drug Pipeline Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Vaccines Drug Pipeline Product/Solution/Service
Table Date of Enter into Cancer Vaccines Drug Pipeline Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Vaccines Drug Pipeline Market Size Share by Type (2014-2019)
Figure Global Cancer Vaccines Drug Pipeline Market Size Market Share by Type (2014-2019)
Table Global Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Vaccines Drug Pipeline Market Size Share by Application (2014-2019)
Figure Global Cancer Vaccines Drug Pipeline Market Size Market Share by Application (2014-2019)
Figure Global Cancer Vaccines Drug Pipeline Revenue Market Share by Application in 2018
Figure United States Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table United States Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table United States Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Figure Europe Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table Europe Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table Europe Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Figure China Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table China Cancer Vaccines Drug Pipeline Market Size by Type (2014-20189) (Million US$)
Table China Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table China Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table China Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Figure Japan Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table Japan Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table Japan Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table Southeast Asia Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table Southeast Asia Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Figure India Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table India Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table India Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table India Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table India Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Figure Central & South America Cancer Vaccines Drug Pipeline Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Vaccines Drug Pipeline Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Vaccines Drug Pipeline Market Share (2018-2019)
Table Central & South America Cancer Vaccines Drug Pipeline Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Vaccines Drug Pipeline Market Share by Type (2014-2019)
Table Central & South America Cancer Vaccines Drug Pipeline Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Vaccines Drug Pipeline Market Share by Application (2014-2019)
Table Eisai Company Details
Table Eisai Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019) (Million US$)
Figure Eisai Revenue Growth Rate in Cancer Vaccines Drug Pipeline Business (2014-2019)
Table Eisai Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Cancer Vaccines Drug Pipeline Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Arbor Pharmaceuticals Company Details
Table Arbor Pharmaceuticals Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)(Million US$)
Figure Arbor Pharmaceuticals Revenue Growth Rate in Cancer Vaccines Drug Pipeline Business (2014-2019)
Table Arbor Pharmaceuticals Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Cancer Vaccines Drug Pipeline Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Revenue in Cancer Vaccines Drug Pipeline Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Cancer Vaccines Drug Pipeline Business (2014-2019)
Table Merck Recent Development
Table Global Cancer Vaccines Drug Pipeline Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Vaccines Drug Pipeline Market Size Share by Regions (2019-2025)
Figure Global Cancer Vaccines Drug Pipeline Market Size Share by Regions in 2025
Figure United States Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Vaccines Drug Pipeline Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Vaccines Drug Pipeline Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Vaccines Drug Pipeline Market Size by Product (2019-2025)
Figure Global Cancer Vaccines Drug Pipeline Market Size by Product in 2025
Table Global Cancer Vaccines Drug Pipeline Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Vaccines Drug Pipeline Market Size by Application (2019-2025)
Figure Global Cancer Vaccines Drug Pipeline Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がんワクチンの世界市場：インサイト・予測 Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and v…- 養殖ワクチンの世界市場：市場規模・現状・予測 It is a biological preparation that improves immunity to a particular disease work on aquaculture.In 2018, the global Aquaculture Vaccine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the glob…
- 癌治療におけるゲノミクスの世界市場：市場規模・現状・予測 Use genomic knowledge to keep prevention of cancerGrowing demand for diagnostics coupled with availability of technologically advanced and cost efficient diagnostic technology is expected to fuel the market growth in coming years. In 2018, the global Genomics In Cancer Care market size was xx millio…
- 世界のRNAワクチン市場：専門的調査 RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …